Jacek Kasznicki
- Cancer Research top 10%
- MicroRNA in disease regulation 4
- Cancer-related molecular mechanisms research 3
- Clinical Biochemistry top 5%
- Advanced Glycation End Products research 4
-
- DNA Repair Mechanisms 6
- Metabolism, Diabetes, and Cancer 5
- PI3K/AKT/mTOR signaling in cancer 3
- Physiology top 10%
-
- Cancer-related Molecular Pathways 4
-
- Adipokines, Inflammation, and Metabolic Diseases 3
Jacek Kasznicki
39 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 108
- Endocrinology, Diabetes and Metabolism 250
- Cancer Research 204
- Clinical Biochemistry 90
- Molecular Biology 574
- Physiology 215
Countries citing papers authored by Jacek Kasznicki
This map shows the geographic impact of Jacek Kasznicki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacek Kasznicki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacek Kasznicki more than expected).
Fields of papers citing papers by Jacek Kasznicki
This network shows the impact of papers produced by Jacek Kasznicki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacek Kasznicki. The network helps show where Jacek Kasznicki may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jacek Kasznicki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 15 | |
| 6 | 2022 | 12 | |
| 7 | 2017 | 19 | |
| 8 | 2016 | 5 | |
| 9 | 2015 | 12 | |
| 10 | 2015 | 26 | |
| 11 | 2014 | 12 | |
| 12 | 2012 | 110 | |
| 13 | Polymorphisms of the DNA repair genes XRCC1 and ERCC4 are not associated with smoking- and drinking-dependent larynx cancer in a Polish population. | 2011 | 22 |
| 14 | 2011 | 40 | |
| 15 | 2011 | 19 | |
| 16 | 2010 | 14 | |
| 17 | 2008 | 48 | |
| 18 | 2005 | 9 | |
| 19 | 2004 | 213 | |
| 20 | The importance of impedance cardiography in monitoring cardiac function in patients with hematological malignancies. | 1993 | 1 |
About Jacek Kasznicki
Jacek Kasznicki is a scholar working on Cancer Research, Clinical Biochemistry and Endocrinology, Diabetes and Metabolism, having authored 41 papers that have together received 1.2k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (6 papers), Metabolism, Diabetes, and Cancer (5 papers), MicroRNA in disease regulation (4 papers), Cancer-related Molecular Pathways (4 papers), Advanced Glycation End Products research (4 papers), PI3K/AKT/mTOR signaling in cancer (3 papers), Adipokines, Inflammation, and Metabolic Diseases (3 papers) and Cancer-related molecular mechanisms research (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (250 citations), Cancer Research (204 citations) and Clinical Biochemistry (90 citations). Jacek Kasznicki has collaborated with scholars based in Poland, United Kingdom and United States. Frequent co-authors include Józef Drzewoski, Agnieszka Śliwińska, Janusz Błasiak, Renata Krupa, Marcin Kosmalski, Monika Żurawska-Kliś, Ireneusz Majsterek, Katarzyna Woźniak, Michał Arabski and Marek Zadrożny.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.